Institut Paoli Calmettes Chronic Lymphatic Leukemia Database
Launched by INSTITUT PAOLI-CALMETTES · Aug 16, 2016
Trial Information
Current as of July 24, 2025
Recruiting
Keywords
ClinConnect Summary
The Institut Paoli Calmettes is conducting a clinical trial to create a database for patients diagnosed with chronic lymphatic leukemia, specifically the B-cell type. This study aims to gather important information about this condition to help improve future treatments and understanding of the disease. The trial is currently looking for participants, and anyone aged between 65 and 74 who has been diagnosed with chronic lymphatic leukemia may be eligible to join. However, individuals with a Matutes score of less than 4 will not qualify for this study.
Participants in this trial can expect to contribute valuable data that may lead to better care for others with the same condition. It’s important to know that this study is primarily focused on collecting information, and it doesn’t involve any new treatments or medications at this stage. Your involvement could help pave the way for advancements in understanding and managing chronic lymphatic leukemia in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Diagnosis of chronic lymphatic leukemia
- Exclusion Criteria:
- • Score of Matutes \<4
About Institut Paoli Calmettes
Institut Paoli-Calmettes (IPC) is a leading cancer research and treatment center located in Marseille, France, dedicated to advancing oncology through innovative clinical trials and comprehensive patient care. With a multidisciplinary approach, IPC integrates cutting-edge research, education, and clinical services to enhance cancer prevention, diagnosis, and treatment. The institute is committed to fostering collaboration among researchers, healthcare professionals, and patients, aiming to translate scientific discoveries into effective therapeutic strategies. As a recognized institution in the field of oncology, IPC plays a pivotal role in shaping the future of cancer care and improving patient outcomes through rigorous and ethical clinical trials.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Marseille, , France
Marseille, Bouches Du Rhône, France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials